PROCR and ovarian cancer: In the ascitic fluid, membrane-associated EPCR, via aPC, can inhibit fibrin formation and participate in fluid expansion in ovarian cancer, whereas under intravascular conditions, sEPCR, due to its trapping action, may be a leading cause of hypercoagulable state associated with cancer.